epirubicin has been researched along with Phlebitis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Roberts, R; Williams, EM; Williams, N | 1 |
| Borley, A; Dolan, G; Hanna, L; Roberts, R; Williams, EM | 1 |
| Arai, K; Inokuchi, M; Ishizaki, J; Kawagishi, A; Kumazaki, M; Miyamoto, K; Nishigami, J; Suga, Y; Takeda, K | 1 |
| Andou, K; Harada, M; Ikeda, T; Ishikawa, M; Kamo, N; Matsui, M; Moriyama, N; Ono, C; Sugimoto, M; Yamamoto, M; Yamaoka, H; Yamaoka, K; Yamauchi, Y | 1 |
| Egashira, N; Nagata, K; Oishi, R; Watanabe, H; Yamada, T; Yamauchi, Y | 1 |
| Eguchi, K; Ikeda, T; Kamatani, R; Kamo, N; Mukouyama, T; Ono, C; Seki, N; Sugimoto, M; Suzuki, T; Yamagami, M; Yamamoto, M | 1 |
1 trial(s) available for epirubicin and Phlebitis
| Article | Year |
|---|---|
[Improvement of epirubicin-induced phlebitis to switch from liquid preparation to lyophilized formulation].
Topics: Breast Neoplasms; Dexamethasone; Dosage Forms; Epirubicin; Female; Freeze Drying; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Male; Middle Aged; Phlebitis; Time Factors | 2009 |
5 other study(ies) available for epirubicin and Phlebitis
| Article | Year |
|---|---|
Chemotherapy induced phlebitis experienced by women with breast cancer following administration of epirubicin using a volumetric infusion pump: an observational study.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Female; Humans; Infusion Pumps; Phlebitis | 2023 |
Epirubicin chemotherapy in women with breast cancer: Alternating arms for intravenous administration to reduce chemical phlebitis.
Topics: Administration, Intravenous; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Injection Site Reaction; Middle Aged; Phlebitis; Prospective Studies | 2019 |
Prevention of venous pain and phlebitis caused by epirubicin hydrochloride.
Topics: Adult; Antibiotics, Antineoplastic; Epirubicin; Female; Humans; Male; Middle Aged; Pain; Phlebitis | 2009 |
Change of formulation decreases venous irritation in breast cancer patients receiving epirubicin.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Epirubicin; Female; Freeze Drying; Humans; Infusions, Intravenous; Logistic Models; Middle Aged; Pharmacists; Phlebitis; Retrospective Studies; Risk Factors | 2012 |
[Promising new injection method to prevent angialgia/phlebitis from epirubicin hydrochloride therapy for breast cancer].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Epirubicin; Female; Humans; Infusions, Intravenous; Middle Aged; Pain; Phlebitis | 2012 |